| [1] | Ahn AC, Tewari M, Poon CS, Phillips RS (2006) The limits of reductionism in medicine: Could systems biology offer an alternative? PLoS Med 3: e208. doi: 10.1371/journal.pmed.0030208.
|
| [2] | Toni R, Malaguti A, Castorina S, Roti E, Lechan RM (2004) New paradigms in neuroendocrinology: Relationships between obesity, systemic inflammation and the neuroendocrine system. J Endocrinol Invest 27: 182–186.
|
| [3] | Crook M (2004) Type 2 diabetes mellitus: A disease of the innate immune system? An update. Diabet Med 21: 203–207.
|
| [4] | Hotamisligil G (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27: Suppl 353–55.
|
| [5] | Shoelson SE, Lee J, Yuan M (2003) Inflammation and the IKK beta/I kappa B/ NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27: Suppl 349–52.
|
| [6] | Finegood D (2003) Obesity, inflammation and type II diabetes. Int J Obes Relat Metab Disord 27: Suppl 34–5.
|
| [7] | Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4–7.
|
| [8] | Sugden MC, Holness MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53: Suppl 171–81.
|
| [9] | Seufert J (2004) Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53: Suppl 1152–158.
|
| [10] | Rosmond R (2003) Stress induced disturbances of the HPA axis: A pathway to type 2 diabetes? Med Sci Monit 9: RA35–RA39.
|
| [11] | Scheen AJ (2003) Pathophysiology of type 2 diabetes. Acta Clin Belg 58: 335–341.
|
| [12] | Schmitz O, Brock B, Hollingdal M, Juhl CB, Porksen N (2002) High-frequency insulin pulsatility and type 2 diabetes: From physiology and pathophysiology to clinical pharmacology. Diabetes Metab 28: 4S14–4S20.
|
| [13] | Sturis J, Polonsky KS, Shapiro ET, Blackman JD, O'Meara NM, et al. (1992) Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 35: 681–689.
|
| [14] | Mao CS, Berman N, Roberts K, Ipp E (1999) Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes 48: 714–721.
|
| [15] | Hollingdal M, Juhl CB, Pincus SM, Sturis J, Veldhuis JD, et al. (2000) Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes. Diabetes 49: 1334–1340.
|
| [16] | O'Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318: 1225–1230.
|
| [17] | Schmitz O, Porksen N, Nyholm B, Skjaerbaek C, Butler PC, et al. (1997) Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. Am J Physiol 272: E218–E226.
|
| [18] | Porksen N, Hollingdal M, Juhl C, Butler P, Veldhuis JD, et al. (2002) Pulsatile insulin secretion: Detection, regulation, and role in diabetes. Diabetes 51: Suppl 1245–254.
|
| [19] | Topp B, Promislow K, deVries G, Miura RM, Finegood DT (2000) A model of beta-cell mass, insulin, and glucose kinetics: Pathways to diabetes. J Theor Biol 206: 605–619.
|
| [20] | Holt TA (2002) A chaotic model for tight diabetes control. Diabet Med 19: 274–278.
|
| [21] | Kroll MH (1999) Biological variation of glucose and insulin includes a deterministic chaotic component. Biosystems 50: 189–201.
|
| [22] | Stahl M, Brandslund I (2003) Measurement of glucose content in plasma from capillary blood in diagnosis of diabetes mellitus. Scand J Clin Lab Invest 63: 431–440.
|
| [23] | Witt MF, White NH, Santiago JV (1983) Roles of site and timing of the morning insulin injection in type 1 diabetes. J Pediatr 103: 528–533.
|
| [24] | Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 5: 77–91.
|
| [25] | ter Braak EW, Woodworth JR, Bianchi R, Cerimele B, Erkelens DW, et al. (1996) Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care 19: 1437–1440.
|
| [26] | Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937–1947.
|
| [27] | Zhang DH, Salto-Tellez M, Chiu LL, Shen L, Koay ES (2003) Tissue microarray study for classification of breast tumors. Life Sci 73: 3189–3199.
|
| [28] | Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, et al. (2004) Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: A tissue microarray study of 284 cases and 18 markers. J Pathol 204: 101–109.
|
| [29] | Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, et al. (2005) A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): Analysis of the GIMEMA 0496 protocol. Blood 105: 3434–3441.
|
| [30] | Rosenwald A, Staudt LM (2003) Gene expression profiling of diffuse large B-cell lymphoma. Leuk Lymphoma 44: Suppl 341–47.
|
| [31] | Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 100: 9991–9996.
|
| [32] | Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, et al. (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109: 1321–1326.
|
| [33] | Giugliano D, Ceriello A, Saccomanno F, Quatraro A, Paolisso G, et al. (1985) Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61: 160–166.
|
| [34] | Baron SH (1982) Salicylates as hypoglycemic agents. Diabetes Care 5: 64–71.
|
| [35] | Canaple L, Kakizawa T, Laudet V (2003) The days and nights of cancer cells. Cancer Res 63: 7545–7552.
|
| [36] | Fu L, Lee CC (2003) The circadian clock: Pacemaker and tumour suppressor. Nat Rev Cancer 3: 350–361.
|
| [37] | Mormont MC, Levi F (2003) Cancer chronotherapy: Principles, applications, and perspectives. Cancer 97: 155–169.
|
| [38] | Huang S (2001) Genomics, complexity and drug discovery: Insights from Boolean network models of cellular regulation. Pharmacogenomics 2: 203–222.
|
| [39] | Kauffman S (1993) The origins of order: Self organization and selection in evolution. New York: Oxford University Press. 734 p.
|
| [40] | Lopes da Silva F, Blanes W, Kalitzin SN, Parra J, Suffczynski P, et al. (2003) Epilepsies as dynamical diseases of brain systems: Basic models of the transition between normal and epileptic activity. Epilepsia 44: Suppl 1272–83.
|
| [41] | Nisbett RE, Peng K, Choi I, Norenzayan A (2001) Culture and systems of thought: Holistic versus analytic cognition. Psychol Rev 108: 291–310.
|
| [42] | Lewton EL, Bydone V (2000) Identity and healing in three Navajo religious traditions: Sa'ah naaghai bik'eh hozh [symbol: see text]. Med Anthropol Q 14: 476–497.
|
| [43] | Schlessinger L, Eddy DM (2002) Archimedes: A new model for simulating health care systems—The mathematical formulation. J Biomed Inform 35: 37–50.
|
| [44] | Eddy DM, Schlessinger L (2003) Archimedes: A trial-validated model of diabetes. Diabetes Care 26: 3093–3101.
|
